Among the 7 HRGs included in the hypoxia risk score model constructed in this study, these 6 genes (LDHA, PGK1, PFKP, DCN, LOX, FBP1) have been extensively reported in previous studies for their roles in tumor hypoxia response and progression. The gene discussed is LOX; the disease is neoplasm.